Clinical Trial Update: Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessing the effects of denosumab in breast cancer patients receiving aromatase inhibitor therapy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: Amgen | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2015-11-06